Literature DB >> 15076249

Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa.

Xavier Anglaret1, Siaka Toure, Gwénola Gourvellec, Amah Tchehy, Lambert Zio, Marcel Zaho, Marie-Cécile Kassi, Jean Lehou, Hélène Coulibaly, Catherine Seyler, Thérèse N'Dri-Yoman, Roger Salamon, Geneviève Chêne.   

Abstract

In HIV cohorts in sub-Saharan Africa, documenting vital status of patients lost to follow-up is a major challenge. The effect of specific vital status investigation procedures (VSIPs) on the number of known deaths has never been shown. We assessed the effects of VSIP on survival estimates in a 4-year prospective cohort study in Abidjan, Côte d'Ivoire. As of June 2000, 545 HIV-infected adults had been followed for 1186 person-years, of whom 233 were documented as deceased. Forty-eight percent of deaths were known through scheduled VSIPs, including reading of the newspaper obituaries (2%), telephone calls to relatives (10%), and home visits (36%). Survival probability at 1, 2, and 3 years was estimated to be 0.79, 0.65, and 0.56, respectively. Without VSIP, survival at 1, 2, and 3 years would have been estimated to be 11, 23, and 30% higher, respectively. In this large African capital city, survival estimates closely depended on VSIPs, mainly home visits. We suggest that the percentage of deaths known through VSIPs would be a useful indicator to be added when reporting survival data from urban HIV cohort studies in sub-Saharan Africa.

Entities:  

Mesh:

Year:  2004        PMID: 15076249     DOI: 10.1097/00126334-200403010-00015

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  35 in total

1.  Electronic medical records and same day patient tracing improves clinic efficiency and adherence to appointments in a community based HIV/AIDS care program, in Uganda.

Authors:  Stella T Alamo; Glenn J Wagner; Pamela Sunday; Rhoda K Wanyenze; Joseph Ouma; Moses Kamya; Robert Colebunders; Fred Wabwire-Mangen
Journal:  AIDS Behav       Date:  2012-02

2.  Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program.

Authors:  Stella T Alamo; Robert Colebunders; Joseph Ouma; Pamela Sunday; Glenn Wagner; Fred Wabwire-Mangen; Marie Laga
Journal:  J Acquir Immune Defic Syndr       Date:  2012-06-01       Impact factor: 3.731

3.  Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya.

Authors:  Paula Braitstein; Adrian Katshcke; Changyu Shen; Edwin Sang; Winstone Nyandiko; Vincent Ooko Ochieng; Rachel Vreeman; Constantin T Yiannoutsos; Kara Wools-Kaloustian; Samwel Ayaya
Journal:  Trop Med Int Health       Date:  2010-05-14       Impact factor: 2.622

4.  A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.

Authors:  Neil French; Stephen B Gordon; Thandie Mwalukomo; Sarah A White; Gershom Mwafulirwa; Herbert Longwe; Martin Mwaiponya; Eduard E Zijlstra; Malcolm E Molyneux; Charles F Gilks
Journal:  Malawi Med J       Date:  2016-09       Impact factor: 0.875

5.  Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.

Authors:  M-F Anaky; J Duvignac; L Wemin; A Kouakoussui; S Karcher; S Touré; C Seyler; P Fassinou; F Dabis; T N'Dri-Yoman; X Anglaret; V Leroy
Journal:  Bull World Health Organ       Date:  2009-12-21       Impact factor: 9.408

6.  Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa.

Authors:  Didier K Ekouevi; Eric Balestre; Franck-Olivier Ba-Gomis; Serge Paul Eholie; Moussa Maiga; Clarisse Amani-Bosse; Albert Minga; Eugène Messou; Papa Salif Sow; Charlotte Lewden; Hamar Allassane Traoré; Emmanuel Bissagnene; François Dabis
Journal:  Trop Med Int Health       Date:  2010-06       Impact factor: 2.622

Review 7.  Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.

Authors:  Matthew P Fox; Sydney Rosen
Journal:  Trop Med Int Health       Date:  2010-06       Impact factor: 2.622

Review 8.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Xavier Anglaret; Landon Myer; Robin Wood
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

9.  Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.

Authors:  Siaka Toure; Bertin Kouadio; Catherine Seyler; Moussa Traore; Nicole Dakoury-Dogbo; Julien Duvignac; Nafissatou Diakite; Sophie Karcher; Christophe Grundmann; Richard Marlink; François Dabis; Xavier Anglaret
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

10.  Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Authors:  Elena Losina; Hapsatou Touré; Lauren M Uhler; Xavier Anglaret; A David Paltiel; Eric Balestre; Rochelle P Walensky; Eugène Messou; Milton C Weinstein; François Dabis; Kenneth A Freedberg
Journal:  PLoS Med       Date:  2009-10-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.